Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
15.71
+1.56 (11.08%)
Mar 14, 2025, 10:55 AM EDT - Market open
Beta Bionics Revenue
Beta Bionics had revenue of $16.71M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $53.03M. In the year 2023, Beta Bionics had annual revenue of $12.00M with 6,601.12% growth.
Revenue (ttm)
$53.03M
Revenue Growth
+6,601.12%
P/S Ratio
3.00
Revenue / Employee
$182,247
Employees
291
Market Cap
673.32M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
Dec 31, 2022 | 179.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBBNX News
- 15 days ago - Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - GlobeNewsWire
- 5 weeks ago - Beta Bionics: A Sugar Rush For This IPO - Seeking Alpha
- 5 weeks ago - U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs - Seeking Alpha
- 5 weeks ago - Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 weeks ago - Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering - GlobeNewsWire
- 2 months ago - U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline - Seeking Alpha
- 2 months ago - Beta Bionics Aims For IPO To Cover Heavy Losses - Seeking Alpha
- 2 months ago - Insulin delivery device maker Beta Bionics files for a $100 million IPO - Renaissance Capital